General Information of the Compound
Compound ID
CP0429419
Compound Name
N'-[6-methyl-2-(1,2,3,5-tetrahydro-1,4-benzodiazepin-4-yl)quinolin-4-yl]ethane-1,2-diamine
    Show/Hide
Structure
Formula
C21H25N5
Molecular Weight
347.466
Canonical SMILES
Cc1ccc2nc(cc(NCCN)c2c1)N1CCNc2ccccc2C1
    Show/Hide
InChI
InChI=1S/C21H25N5/c1-15-6-7-19-17(12-15)20(23-9-8-22)13-21(25-19)26-11-10-24-18-5-3-2-4-16(18)14-26/h2-7,12-13,24H,8-11,14,22H2,1H3,(H,23,25)
    Show/Hide
InChIKey
ZRZPDYMOTSONKL-UHFFFAOYSA-N
Physicochemical Property
logP
3.34592
Rotatable Bonds
4
Heavy Atom Count
26
Polar Areas
66.21
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
5
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 71254547
ChEMBL ID
CHEMBL4177084
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00459, Fusion glycoprotein F0
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000668 HEp-2 Homo sapiens (Human)  1
1
EC50 = 230 nM
   TI
   LI
   LO
   TS